Literature DB >> 32066209

A Survey of the Knowledge of and Testing Rate for Hepatitis C in the General Population in South Korea.

Gwang Hyeon Choi1, Eun Sun Jang1, Jin-Wook Kim1, Sook-Hyang Jeong1.   

Abstract

Background/Aims: To eliminate hepatitis C virus (HCV) infection, improving public knowledge of and access to HCV screening and treatment is essential. The aim of this study was to evaluate the knowledge of and testing rate for HCV and the opinions about the inclusion of the HCV test in the National Health Examination (NHE) among the general population in South Korea.
Methods: A telephone interview survey was conducted by an independent research company using a 16 item-questionnaire (demographics, knowledge of HCV, testing and results, need for screening) in May 2019. The sample population consisted of 1,003 adult Korean residents adjusted by age, sex, and area according to the standard Korean population in 2019.
Results: Among the 1,003 participants (505 women, mean age of 47.9 years), 56.4% recognized HCV; 44.4% understood that HCV is transmittable, and 56.8% thought that HCV is curable by medication. The recognition rate tended to increase with an increasing level of education. Testing for anti-HCV antibodies was reported by 91 people (9.1%); among them, 10 people (11.0%) reported a positive result, and eight people received treatment. The common reasons for HCV testing were a health check-up (58.5%), a physician's recommendation (11.0%) and elevated liver enzyme levels (10.7%). The majority of the population (75.1%) agreed with the integration of HCV into the NHE. Conclusions: The level of knowledge of HCV is suboptimal, and the self-reported testing rate for HCV is less than 10%; however, once HCV infection is diagnosed, the treatment rate seems to be high in South Korea. More active campaigns and effective screening are needed.

Entities:  

Keywords:  Awareness; Hepatitis C, chronic; Knowledge; Public health; Transmission

Year:  2020        PMID: 32066209     DOI: 10.5009/gnl19296

Source DB:  PubMed          Journal:  Gut Liver        ISSN: 1976-2283            Impact factor:   4.519


  2 in total

1.  Prior antiviral treatment and mortality among patients with hepatitis C virus-related hepatocellular carcinoma: A national cohort study.

Authors:  Dong Hyun Sinn; Danbee Kang; Yun Soo Hong; Kwang Cheol Koh; Eliseo Guallar; Juhee Cho; Geum-Youn Gwak
Journal:  PLoS One       Date:  2021-08-03       Impact factor: 3.240

Review 2.  Cost-effectiveness of chronic hepatitis C screening and treatment.

Authors:  Hye Won Lee; Hankil Lee; Beom Kyung Kim; Young Chang; Jae Young Jang; Do Young Kim
Journal:  Clin Mol Hepatol       Date:  2021-12-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.